OPEN PROSPECTIVE TRIAL INVESTIGATING PHARMACOKINETICS, TOLERABILITY AND SAFETY OF A NEW 10% HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INFUSION (IVIG) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE

被引：0
|
作者：
Krivan, G. [1 ]
Koenigs, C. [2 ]
Bernatowska, E. [3 ]
Marodi, L. [4 ]
Erdos, M. [4 ]
Salama, A. [5 ]
Linde, R. [2 ]
机构：
[1] United St Istvan & St Laszlo Hosp, Dept Pediat Hematol & Stem Cell Transplantat, Budapest, Hungary
[2] Goethe Univ Frankfurt, Dept Pediat Hemostasis & Immunodeficiency, Frankfurt, Germany
[3] Childrens Mem Hlth Inst, Dept Immunol, Warsaw, Poland
[4] Univ Debrecen, Med & Hlth Sci Ctr, Dept Infectol & Pediat Immunol, H-4012 Debrecen, Hungary
[5] Univ Med Berlin, Inst Transfus Med, Berlin, Germany
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [21] Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia
    Björkander, J
    Nikoskelainen, J
    Leibl, H
    Lanbeck, P
    Wallvik, J
    Lumio, JT
    Braconier, JH
    Pavlova, BG
    Birthistle, K
    Engl, W
    Walter, S
    Ehrlich, HJ
    VOX SANGUINIS, 2006, 90 (04) : 286 - 293
  • [22] Safety and tolerability of increased rate of infusion of intravenous immunoglobulin G, 10% in antibody-deficient patients
    Gelfand, Erwin W.
    Hanna, Kim
    JOURNAL OF CLINICAL IMMUNOLOGY, 2006, 26 (03) : 284 - 290
  • [23] Safety and Tolerability of Increased Rate of Infusion of Intravenous Immunoglobulin G, 10% in Antibody-Deficient Patients
    Erwin W. Gelfand
    Kim Hanna
    Journal of Clinical Immunology, 2006, 26 : 284 - 290
  • [24] Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open-label trial
    Farkas, Mark Kristof
    Kang, Harriet
    Fogarasi, Andras
    Bozorg, Ali
    James, Gareth D.
    Krauwinkel, Walter
    Morita, Diego
    Will, Edgar
    Elshoff, Jan-Peer
    EPILEPSIA, 2022, 63 (04) : 855 - 864
  • [25] Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Pediatric Patients with Epilepsy: An Open-label Trial
    Farkas, M.
    Kang, H.
    Fogarasi, A.
    Bozorg, A.
    James, G.
    Krauwinkel, W.
    Morita, D.
    Will, E.
    Elshoff, J-P
    ANNALS OF NEUROLOGY, 2021, 90 : S127 - S127
  • [26] Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: an open-label trial
    Farkas, Mark Kristof
    Kang, Harriet
    Fogarasi, Andras
    Bozorg, Ali
    James, Gareth
    Krauwinkel, Walter
    Morita, Diego
    Will, Edgar
    Elshoff, Jan-Peer
    EPILEPSIA, 2021, 62 : 143 - 144
  • [27] A multicentre, prospective, non-randomized, sequential, open-label trial to demonstrate the bioequivalence between intravenous immunoglobulin new generation (IGNG) and standard IV immunoglobulin (IVIG) in adult patients with primary immunodeficiency (PID)
    Viallard, J. -F.
    Brion, J. -P.
    Malphettes, M.
    Durieu, I.
    Gardernbas, M.
    Schleinitz, N.
    Hoarau, C.
    Lazaro, E.
    Puget, S.
    REVUE DE MEDECINE INTERNE, 2017, 38 (09): : 578 - 584
  • [28] SAFETY/TOLERABILITY OF THE NEW HUMAN SUBCUTANEOUS IMMUNOGLOBULIN (SCIG 20%) IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD)
    Paris, Kenneth
    Derfalvi, Beata
    Hussain, Iftikhar
    Haddad, Elie
    Darter, Amy
    Doralt, Jennifer
    Engl, Werner
    McCoy, Barbara
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (02) : 201 - 202
  • [29] New 10% liquid intravenous immunoglobulin in multifocal motor neuropathy: Prospective study of efficacy, safety and tolerability
    Cats, E. A.
    van der Pol, W. L.
    van den Berg-Vos, R. M.
    Wokke, J. H. J.
    Franssen, H.
    van den Berg, L. H.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2008, 13 (02) : 163 - 164
  • [30] A clinical trial protocol to evaluate the safety and pharmacokinetics of subcutaneously administered immunoglobulin in patients with primary immunodeficiency
    Vong, Linda
    LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS, 2019, 6 (02): : 75 - 86
12345